VA HB 917
Status unknownCompounding pharmacies; use of bulk drug substances, recordkeeping.
Virginia · 2026 Regular Session · lower
Quick answers
Did VA HB 917 pass?
The current status of VA HB 917 is not known from the official record. Latest recorded action (2026-01-27): Continued to next session in Health and Human Services (Voice Vote)
What is VA HB 917 about?
Board of Pharmacy; compounding pharmacies; use of bulk drug substances; recordkeeping. Establishes additional requirements for when pharmacists may use bulk drug substances in compounding and specifies prohibitions on pharmacist use of (i) bulk drug substances that were withdrawn or removed from the market for reasons of safety and effectiveness or were covered by an investigational new drug application and not approved and (ii) compounded drug products that are essentially a copy of commercially available drug products. The bill permits the Board of Pharmacy to request records of all compounded drug products and requires pharmacists to furnish such records within 48 hours of such request or within a reasonable time as determined by the Board. The bill also permits the Board of Pharmacy to submit any information related to investigations, disciplinary proceedings, or inspection of a licensee to the National Association of Boards of Pharmacy.
Who sponsors VA HB 917?
Rodney T. Willett is the primary sponsor of VA HB 917, joined by 1 cosponsor.
Description
Board of Pharmacy; compounding pharmacies; use of bulk drug substances; recordkeeping. Establishes additional requirements for when pharmacists may use bulk drug substances in compounding and specifies prohibitions on pharmacist use of (i) bulk drug substances that were withdrawn or removed from the market for reasons of safety and effectiveness or were covered by an investigational new drug application and not approved and (ii) compounded drug products that are essentially a copy of commercially available drug products. The bill permits the Board of Pharmacy to request records of all compounded drug products and requires pharmacists to furnish such records within 48 hours of such request or within a reasonable time as determined by the Board. The bill also permits the Board of Pharmacy to submit any information related to investigations, disciplinary proceedings, or inspection of a licensee to the National Association of Boards of Pharmacy.
- Introduced
- 2026-01-13
- Latest action
- 2026-01-27 — Continued to next session in Health and Human Services (Voice Vote)
- Bill type
- bill
- Last updated
- —
Sponsors
- Rodney T. Willettprimary
- Elizabeth R. Guzmancosponsor
Committees
Not provided by source.
Action timeline
2026-01-13
Prefiled and ordered printed; Offered 01-14-2026 26105003D
filing,introduction
2026-01-13
Referred to Committee on Health and Human Services
referral-committee
2026-01-26
Fiscal Impact Statement from Department of Planning and Budget (HB917)
2026-01-27
Continued to next session in Health and Human Services (Voice Vote)
Versions
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:35:59.552682Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=VA&identifier=HB 917. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.